Literature DB >> 29263136

Foetal growth restriction in mice modifies postnatal airway responsiveness in an age and sex-dependent manner.

Kimberley C W Wang1,2, Alexander N Larcombe3,4, Luke J Berry3, Jude S Morton5, Sandra T Davidge5, Alan L James6, Peter B Noble3,2,7.   

Abstract

Epidemiological studies demonstrate an association between intrauterine growth restriction (IUGR) and asthma; however the underlying mechanism is unknown. We investigated the impact of maternal hypoxia-induced IUGR on airway responsiveness in male and female mice during juvenility and adulthood. Pregnant BALB/c mice were housed under hypoxic conditions for gestational days 11-17.5 and then returned to normoxic conditions for the remainder of pregnancy. A control group was housed under normoxic conditions throughout pregnancy. Offspring were studied at 2 weeks (juveniles) and 8 weeks (adults), where lung volume was assessed by plethysmography, airway responsiveness to methacholine determined by the forced oscillation technique and lungs fixed for morphometry. IUGR offspring were lighter at birth, exhibited "catch-up growth" by 2 weeks, but were again lighter in adulthood. IUGR males were "hyper-responsive" at 2 weeks and "hypo-responsive" as adults, in contrast with IUGR females who were hyper-responsive in adulthood. IUGR males had increased inner and total wall thickness at 2 weeks which resolved by adulthood, while airways in IUGR females were structurally normal throughout life. There were no differences in lung volume between Control and IUGR offspring at any age. Our data demonstrate changes in airway responsiveness as a result of IUGR that could influence susceptibility to asthma development and contribute to sexual dimorphism in asthma prevalence which switches from a male dominated disease in early life to a female dominated disease in adulthood.
© 2018 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  airway responsiveness; asthma; hypoxia; intrauterine growth restriction; sex

Mesh:

Year:  2018        PMID: 29263136     DOI: 10.1042/CS20171554

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  6 in total

1.  [Establishment of an ovalbumin-induced bronchial asthma model in mice with intrauterine growth retardation].

Authors:  Hong-Ling Wei; Yan Xing; Wei Zhou; Xin-Li Wang; Hui Zhang; Jie Ding
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-12

2.  Single-Cell Analysis Identifies Thymic Maturation Delay in Growth-Restricted Neonatal Mice.

Authors:  Wendi A Bacon; Russell S Hamilton; Ziyi Yu; Jens Kieckbusch; Delia Hawkes; Ada M Krzak; Chris Abell; Francesco Colucci; D Stephen Charnock-Jones
Journal:  Front Immunol       Date:  2018-11-01       Impact factor: 7.561

3.  Calcium-Sensing Receptor Contributes to Hyperoxia Effects on Human Fetal Airway Smooth Muscle.

Authors:  Anne M Roesler; Jovanka Ravix; Colleen M Bartman; Brijeshkumar S Patel; Marta Schiliro; Benjamin Roos; Lisa Nesbitt; Christina M Pabelick; Richard J Martin; Peter M MacFarlane; Y S Prakash
Journal:  Front Physiol       Date:  2021-03-15       Impact factor: 4.566

4.  Pharmacological ablation of the airway smooth muscle layer-Mathematical predictions of functional improvement in asthma.

Authors:  Graham M Donovan; Kimberley C W Wang; Danial Shamsuddin; Tracy S Mann; Peter J Henry; Alexander N Larcombe; Peter B Noble
Journal:  Physiol Rep       Date:  2020-06

5.  Mechanical Abnormalities of the Airway Wall in Adult Mice After Intrauterine Growth Restriction.

Authors:  Peter B Noble; Darshinee Kowlessur; Alexander N Larcombe; Graham M Donovan; Kimberley C W Wang
Journal:  Front Physiol       Date:  2019-08-23       Impact factor: 4.566

Review 6.  Prenatal Hypoxia Affects Foetal Cardiovascular Regulatory Mechanisms in a Sex- and Circadian-Dependent Manner: A Review.

Authors:  Hana Sutovska; Katarina Babarikova; Michal Zeman; Lubos Molcan
Journal:  Int J Mol Sci       Date:  2022-03-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.